Hepatobiliary cancers in South America: disparity strikes

Jose D. Debes; A. Boonstra; Domingo Balderramo; Angelo Z. Mattos; M. Arrese

doi:10.1016/S2468-1253(19)30188-8

Hepatobiliary cancers in South America: disparity strikes

Jose D. Debes, A. Boonstra, Domingo Balderramo, Angelo Z. Mattos, M. Arrese

Medicine - Infectious Disease and International

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	581
Number of pages	1
Journal	The Lancet Gastroenterology and Hepatology
Volume	4
Issue number	8
DOIs	https://doi.org/10.1016/S2468-1253(19)30188-8
State	Published - Aug 2019

Bibliographical note

Funding Information:
The European South American Consortium to Assess Liver-Originated Neoplasia (ESCALON) project has received funding from the EU Horizon 2020 research and innovation programme under grant agreement number 825510 . It is partially funded by the Robert Wood Johnson Foundation , Harold Amos Medical Faculty Development Program, and NIH-NCI R21 CA215883-01A1 to JDD. AB reports grants from Janssen Pharma, Gilead Sciences, and Fujirebio, outside the submitted work.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/S2468-1253(19)30188-8

OpenUrl availability

Full text

Cite this

@article{adb8f00fb30b482e8cfedfdc6da132b0,

title = "Hepatobiliary cancers in South America: disparity strikes",

author = "Debes, {Jose D.} and A. Boonstra and Domingo Balderramo and Mattos, {Angelo Z.} and M. Arrese",

note = "Funding Information: The European South American Consortium to Assess Liver-Originated Neoplasia (ESCALON) project has received funding from the EU Horizon 2020 research and innovation programme under grant agreement number 825510 . It is partially funded by the Robert Wood Johnson Foundation , Harold Amos Medical Faculty Development Program, and NIH-NCI R21 CA215883-01A1 to JDD. AB reports grants from Janssen Pharma, Gilead Sciences, and Fujirebio, outside the submitted work. ",

year = "2019",

month = aug,

doi = "10.1016/S2468-1253(19)30188-8",

language = "English (US)",

volume = "4",

pages = "581",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Limited",

number = "8",

}

TY - JOUR

T1 - Hepatobiliary cancers in South America

T2 - disparity strikes

AU - Debes, Jose D.

AU - Boonstra, A.

AU - Balderramo, Domingo

AU - Mattos, Angelo Z.

AU - Arrese, M.

N1 - Funding Information: The European South American Consortium to Assess Liver-Originated Neoplasia (ESCALON) project has received funding from the EU Horizon 2020 research and innovation programme under grant agreement number 825510 . It is partially funded by the Robert Wood Johnson Foundation , Harold Amos Medical Faculty Development Program, and NIH-NCI R21 CA215883-01A1 to JDD. AB reports grants from Janssen Pharma, Gilead Sciences, and Fujirebio, outside the submitted work.

PY - 2019/8

Y1 - 2019/8

UR - http://www.scopus.com/inward/record.url?scp=85068461423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068461423&partnerID=8YFLogxK

U2 - 10.1016/S2468-1253(19)30188-8

DO - 10.1016/S2468-1253(19)30188-8

M3 - Letter

C2 - 31292069

AN - SCOPUS:85068461423

SN - 2468-1253

VL - 4

SP - 581

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 8

ER -

Hepatobiliary cancers in South America: disparity strikes

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this